secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0000950170-24-081526
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen appoints Kevin Smith as GC and EVP Business Development; Jason Somer departs July 19
--------------------------------------------------------------------------------

- Jason Somer, EVP, General Counsel & Secretary, to separate from Inogen on July 19, 2024.
- Kevin P. Smith appointed as EVP, Business Development, General Counsel & Secretary, effective July 22, 2024.
- Smith will receive base salary of $420,000, target bonus of 50%, and $500,000 in RSUs vesting over 3 years.
- Smith previously served as GC and EVP Business Development at Sirtex Medical since 2018.
- Separation and appointment are part of leadership transition; Smith's employment agreement filed as Exhibit 10.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000095017024081526/0000950170-24-081526-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000095017024081526/ingn-20240702.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-081526

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer